Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FDRBG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,929
Award facts
- Contract value 100% obligated
- $18,929.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 12, 2025, for the supply of Nucala 100 mg/ml auto-injectors, a prescription medication used to treat severe eosinophilic asthma and other conditions. This firm fixed-price delivery order, valued at $18,929.00, carries an ultimate completion date of September 15, 2025, and will be performed in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market leveraging its status as a woman-owned small business. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, with a robust track record of federal contracting since 2001. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems across the nation. The larger SPE2DB indefinite delivery contract positions DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, enabling efficient procurement of medications and medical supplies essential to military health operations globally.
Quick answers
Who was awarded contract SPE2DB25FDRBG?
SPE2DB25FDRBG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FDRBG worth?
The government has obligated $18,929 on SPE2DB25FDRBG.
Is contract SPE2DB25FDRBG an order under another contract?
Yes. SPE2DB25FDRBG is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRBG competed?
The extent of competition for SPE2DB25FDRBG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award